AJUBA and cancer: On the other hand, as the Hippo pathway is also an autoinhibitory pathway, the control of Hippo pathway activity depends on several internal inhibitors, such as FATs and AJUBA, and the functional MST-LATS-YAP/TAZ cascade, while abnormalities in Hippo signaling can be linked to several human cancers [32].